sur BioNxt Solutions Inc. (CVE:BNXT)
BioNxt Solutions Issues New Stock Options
BioNxt Solutions Inc., a bioscience company, has announced the granting of a total of 750,000 stock options under their stock option plan. These options, awarded to certain insiders, consultants, and an employee, can be exercised to acquire common shares at a price of $0.33 over a three-year period. These options vested immediately.
Moreover, the company granted an additional 2,650,000 options. These also allow acquisition of common shares at $0.33 but over a five-year span. Immediate vesting applies here as well. The option plan had received shareholder approval on November 7, 2025.
Per Canadian Securities Exchange policies, both the options and any resulting common shares will be subject to a four-month hold period.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BioNxt Solutions Inc.